Aspirin Increases Nitric Oxide Formation in Chronic Stable Coronary Disease
Author(s) -
Scott Hetzel,
David L. DeMets,
R Schneider,
Steven Borzak,
Wendy R. Schneider,
Victor L. Serebruany,
H. Schröder,
Charles H. Hennekens
Publication year - 2013
Publication title -
journal of cardiovascular pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 50
eISSN - 1940-4034
pISSN - 1074-2484
DOI - 10.1177/1074248413482753
Subject(s) - medicine , aspirin , nitric oxide , gastroenterology , randomized controlled trial , confidence interval , cardiology
There are no published randomized data on secondary prevention in humans about whether aspirin affects nitric oxide (NO) formation. In patients with chronic stable coronary disease, we tested whether aspirin at clinically relevant doses increases NO formation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom